Cardiovascular reactivity after blockade of angiotensin AT1 receptors in the experimental model of tilting test in conscious rats

British Journal of Pharmacology

Volumn 153, Issue 5, 2008, Pages 966-971

  Bedette, D ^a   Santos, R A S ^a   Fontes, M A P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin receptors; Conscious rats; Losartan; Orthostatic stress; Tilt test

Indexed keywords

ATENOLOL; LOSARTAN; PRAZOSIN; TELMISARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TILT TABLE TEST;

EID: 40149090511     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707652     Document Type: Article

References (25)

1. Battershill AJ, Scott LJ (2006). Telmisartan: a review of its use in the management of hypertension. Drugs 66: 51–83.
2. Bedette D, Fontes MAP (2005). Padronização de um método para avaliação das alterações cardiovasculares produzidas pela manobra de estresse ortostático em ratos acordados. XIII Encontro de Pesquisa em Fisiologia e Farmacologia, MG, Brasil, Abstract. vol. 1 19. PGFisfar: Belo Horizonte, MG, Brazil.
3. Colson P, Ryckwaert F, Coriat P (1999). Renin angiotensin system antagonists and anesthesia. Anesth Analg 89: 1143–1155.
4. Dampney RA, Coleman MJ, Fontes MA, Hirooka Y, Horiuchi J, Li YW et al. (2002). Central mechanisms underlying short‐ and long‐term regulation of the cardiovascular system. Clin Exp Pharmacol Physiol 29: 261–268.
5. Dampney RA, Horiuchi J, Tagawa T, Fontes MA, Potts PD, Polson JW (2003). Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 177: 209–218.
6. de Moura MM, dos Santos RA, Fontes MA (2005). Evidence for a functional cardiac interaction between losartan and angiotensin‐(1–7) receptors revealed by orthostatic tilting test in rats. Br J Pharmacol 144: 755–760.
7. Ferrario CM (2006). Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 7: 3–14.
8. Fontes MA, Baltatu O, Caligiorne SM, Campagnole‐Santos MJ, Ganten D, Bader M et al. (2000). Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats. Physiol Genomics 2: 137–142.
9. Fontes MA, Martins Pinge MC, Naves V, Campagnole‐Santos MJ, Lopes OU, Khosla MC et al. (1997). Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res 750: 305–310.
10. Goa KL, Wagstaff AJ (1996). Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 51: 820–845.
11. Gohlke P, Weiss S, Jansen A, Wienen W, Stangier J, Rascher W et al. (2001). AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther 298: 62–70.
12. Goldstein DS, Robertson D, Esler M, Straus SE, Eisenhofer G (2002). Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 137: 753–763.
13. Hashimoto Y, Ohashi R, Minami K, Narita H (1999). Comparative study of TA‐606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension. Jpn J Pharmacol 81: 63–72.
14. Humphrey SJ, McCall RB (1982). A rat model for predicting orthostatic hypotension during acute and chronic antihypertensive drug therapy. J Pharmacol Methods 7: 25–34.
15. Lamarre‐Cliche M, Cusson J (2001). The fainting patient: value of the head‐upright tilt‐table test in adult patients with orthostatic intolerance. CMAJ 164: 372–376.
16. Li Z, Bains JS, Ferguson AV (1993). Functional evidence that the angiotensin antagonist losartan crosses the blood–brain barrier in the rat. Brain Res Bull 30: 33–39.
17. Maillard MP, Perregaux C, Centeno C, Stangier J, Wienen W, Brunner HR et al. (2002). In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist. J Pharmacol Exp Ther 302: 1089–1095.
18. Miki K, Hayashida Y, Tajima F, Iwamoto J, Shiraki K (1989). Renal sympathetic nerve activity and renal responses during head‐up tilt in conscious dogs. Am J Physiol 257: R337–R343.
19. Mirenda JV, Grissom TE (1991). Anesthetic implications of the renin–angiotensin system and angiotensin‐converting enzyme inhibitors. Anesth Analg 72: 667–683.
20. Ohlstein EH, Gellai M, Brooks DP, Vickery L, Jugus J, Sulpizio A et al. (1992). The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism. J Pharmacol Exp Ther 262: 595–601.
21. Rieckert H (1996). Orthostatic hypotension: how to avoid it during antihypertensive therapy. Am J Hypertens 9: 155S–159S.
22. Sheriff MJ, Fontes MA, Killinger S, Horiuchi J, Dampney RA (2006). Blockade of AT1 receptors in the rostral ventrolateral medulla increases sympathetic activity under hypoxic conditions. Am J Physiol Regul Integr Comp Physiol 290: R733–R740.
23. Shimokawa A, Kunitake T, Takasaki M, Kannan H (1998). Differential effects of anesthetics on sympathetic nerve activity and arterial baroreceptor reflex in chronically instrumented rats. J Auton Nerv Syst 72: 46–54.
24. Simpson KL, McClellan KJ (2000). Losartan: a review of its use, with special focus on elderly patients. Drugs Aging 16: 227–250.
25. Weaver LC, Stein RD (1989). Effects of spinal cord transection on sympathetic discharge in decerebrate‐unanesthetized cats. Am J Physiol 257: R1506–R1511.